Cancers, Vol. 11, Pages 2020: Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma

In conclusion, low serum levels of CCL3 were associated with an increased risk of VTE. CCL3 might serve as a potential biomarker to predict VTE risk in patients with glioma.

Source: Cancers - December 13, 2019 Category: Cancer & Oncology Authors: Pegah Mir Seyed Nazari Christine Marosi Florian Moik Julia Riedl Öykü Özer Anna Sophie Berghoff Matthias Preusser Johannes A. Hainfellner Ingrid Pabinger Gerhard J. Zlabinger Cihan Ay Tags: Article Source Type: research